NDC 68382-447 – Bosentan
Bosentan 125 mg/1 · Tablet, Coated · Oral
Product NDC68382-447
Product details
- Brand name
- Bosentan
- Generic name
- Bosentan
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Dosage form
- Tablet, Coated
- Route
- Oral
- Marketing category
- ANDA · ANDA207760
- Marketed since
- May 1, 2019
- Listing expires
- December 31, 2027
- Pharmacologic class
- Endothelin Receptor Antagonist
Active ingredients
- Bosentan 125 mg/1
Package NDC codes (5)
| Package NDC | Description | Since |
|---|---|---|
| 68382-447-01 | 100 TABLET, COATED in 1 BOTTLE (68382-447-01) | May 1, 2019 |
| 68382-447-05 | 500 TABLET, COATED in 1 BOTTLE (68382-447-05) | May 1, 2019 |
| 68382-447-14 | 60 TABLET, COATED in 1 BOTTLE (68382-447-14) | May 1, 2019 |
| 68382-447-28 | 180 TABLET, COATED in 1 BOTTLE (68382-447-28) | May 1, 2019 |
| 68382-447-77 | 10 BLISTER PACK in 1 CARTON (68382-447-77) / 10 TABLET, COATED in 1 BLISTER PACK (68382-447-30) | May 1, 2019 |
Other Bosentan products
- 68382-446 Bosentan 62.5 mg/1 · Tablet, Coated · Zydus Pharmaceuticals USA Inc.
- 0591-2511 Bosentan 62.5 mg/1 · Tablet, Film Coated · Actavis Pharma, Inc.
- 0591-2512 Bosentan 125 mg/1 · Tablet, Film Coated · Actavis Pharma, Inc.
- 68180-340 Bosentan 32 mg/1 · Tablet, For Suspension · Lupin Pharmaceuticals, Inc.
- 47335-038 Bosentan 62.5 mg/1 · Tablet, Film Coated · Sun Pharmaceutical Industries, Inc.
- 47335-039 Bosentan 125 mg/1 · Tablet, Film Coated · Sun Pharmaceutical Industries, Inc.
- 70771-1017 Bosentan 62.5 mg/1 · Tablet · Zydus Lifesciences Limited
- 70771-1018 Bosentan 125 mg/1 · Tablet · Zydus Lifesciences Limited
- 70771-1908 Bosentan 32 mg/1 · Tablet, For Suspension · Zydus Lifesciences Limited
- 70710-1508 Bosentan 32 mg/1 · Tablet, For Suspension · Zydus Pharmaceuticals USA Inc.